Founding Account Executive - Biotech​/Pharma

A hedge fund analyst covering biotech and pharma has to watch hundreds of stocks at once: press releases, SEC filings, management calls, updates on government websites, clinical data publications, and more. Obi9 ingests all of it and surfaces what matters.

Obi9 is a real-time research platform for investors in biotech and pharma. It covers 700+ therapeutics companies and pulls in what moves them as it happens: SEC filings, press releases, earnings calls and transcripts, medical conferences, clinical trial registries in the US, EU and China, and FDA databases.

We use AI to read each document as it arrives and summarize what changed, alongside the numbers analysts would otherwise rebuild by hand: fully diluted share counts, enterprise value and upcoming catalysts. Clients get it in the web and mobile terminal, as alerts in Slack, Teams or their IB chat, inside their AI assistant, and in their own systems through our API.

PMs and analysts at biotech hedge funds use Obi9 every day, and several funds pay for it today. We have closed our seed round. Until now the founders have run sales, and we are hiring a founding account executive to take over the commercial side and turn it into a repeatable motion.

Portfolio managers and analysts at hedge funds investing in biotech and pharma.

• Take over the founders' client relationships and pipeline, including the hedge funds already paying for Obi9, and own revenue from there.
• Run the full cycle with PMs and analysts: prospecting, demos, trials, closing and renewals.
• Build and lead the first sales team. There is budget for SDRs or contractors to run the top of the funnel under your direction.
• Meet clients at industry conferences. There is a conference budget for travel and client meetings when needed; otherwise travel is light.
• Bring what you hear from clients back to the product team.

You report to the CEO. As the team grows, this role is the path to Head of Sales.

$160-185k base and $275-320k OTE, with uncapped commission, plus equity. While you ramp, commission is guaranteed: 100% of target in months 1-2, 50% in months 3-4 and 25% in months 5-6.

Someone who has sold to this exact buyer for years: you know which funds are out there, what their investment teams care about, how they buy and the payment terms they expect. You are comfortable owning the number before there is a playbook, and you would rather build the sales motion than run someone else's.

• Driving your own work streams with minimal, and often ambiguous, guidance.
• Knowing your way around the industry conference circuit.
• Meeting clients in person when it helps open, close or grow an account.
• 5+ years selling research, data or analytics subscriptions to investment firms.
• A track record of opening brand new client relationships.
• Working knowledge of biotech catalysts: trial phases and readouts, PDUFA dates and SEC filings.
• Fluent business English.
• Based in New York City (the role is remote), able to meet clients in person when needed.
• An existing network of biotech and healthcare investors in the US.